Search

Harvey Rabin

from Braddock Heights, MD
Get Report
Related to:
Evelyn M Rabin, 80
Connected to:
Alexander Rabin, 96Aron D Rabin, 50Barry S Rabin, 67Beth Rabin, 66Jared R Rabin, 40Kenneth H Rabin, 81Lani L Rabin, 70Michelle Rabin, 74Moshe Y Rabin, 42Nicholas J Rabin, 47

Harvey Rabin Phones & Addresses

  • Braddock Heights, MD

Publications

Us Patents

Treatment Of Neoplasms With Viruses

View page
US Patent:
7470426, Dec 30, 2008
Filed:
Apr 17, 2000
Appl. No.:
09/958809
Inventors:
Michael S. Roberts - Walkersville MD, US
Robert M. Lorence - Bethesda MD, US
William S. Groene - New Market MD, US
Harvey Rabin - Rockville MD, US
Reid W. von Borstel - Potomac MD, US
Assignee:
Wellstat Biologics Corporation - Gaithersburg MD
International Classification:
A61K 48/00
C12N 7/01
US Classification:
424 932, 4352351, 435456
Abstract:
The subject invention relates to viruses that are able to replicate and thereby kill neoplastic cells with a deficiency in the IFN-mediated antiviral response, and their use in treating neoplastic disease including cancer and large tumors. RNA and DNA viruses are useful in this regard. The invention also relates to methods for the selection, design, purification and use of such viruses for cancer therapy.

Treatment Of Neoplasms With Rna Viruses

View page
US Patent:
7780962, Aug 24, 2010
Filed:
Jun 13, 2002
Appl. No.:
10/167652
Inventors:
Michael S. Roberts - Walkersville MD, US
Robert M. Lorence - Bethesda MD, US
William S. Groene - New Market MD, US
Harvey Rabin - Rockville MD, US
Reid W. von Borstel - Potomac MD, US
Assignee:
Wellstat Biologics Corporation - Gaithersburg MD
International Classification:
A01N 63/00
A01N 65/00
US Classification:
424 936, 424 931
Abstract:
The subject invention relates to viruses that are able to replicate and thereby kill neoplastic cells with a deficiency in the IFN-mediated antiviral response, and their use in treating neoplastic disease including cancer and large tumors. RNA and DNA viruses are useful in this regard. The invention also relates to methods for the selection, design, purification and use of such viruses for cancer therapy.

Treatment Of Neoplasms With Viruses

View page
US Patent:
8105578, Jan 31, 2012
Filed:
Jan 29, 2007
Appl. No.:
11/698947
Inventors:
Michael S. Roberts - Walkersville MD, US
Robert M. Lorence - Bethesda MD, US
William S. Groene - New Market MD, US
Harvey Rabin - Rockville MD, US
Reid W. von Borstel - Potomac MD, US
Assignee:
Wellstat Biologics Corporation - Gaithersburg MD
International Classification:
A01N 63/00
C12N 7/00
US Classification:
424 936, 4352351
Abstract:
The subject invention relates to viruses that are able to replicate and thereby kill neoplastic cells with a deficiency in the IFN-mediated antiviral response, and their use in treating neoplastic disease including cancer and large tumors. RNA and DNA viruses are useful in this regard. The invention also relates to methods for the selection, design, purification and use of such viruses for cancer therapy.

Infection And Treatment Of Neoplasms With Vesicular Stomatitis Virus

View page
US Patent:
8043612, Oct 25, 2011
Filed:
Nov 18, 2008
Appl. No.:
12/292377
Inventors:
Michael S. Roberts - Walkersville MD, US
Robert M. Lorence - Bethesda MD, US
William S. Groene - New Market MD, US
Harvey Rabin - Rockville MD, US
Reid W. von Borstel - Potomac MD, US
Assignee:
Wellstat Biologics Corporation - Gaithersburg MD
International Classification:
A01N 63/02
C12N 7/01
C12N 15/00
US Classification:
424 936, 424 932, 4352351, 4353201
Abstract:
The subject invention relates to viruses that are able to replicate and thereby kill neoplastic cells with a deficiency in the IFN-mediated antiviral response, and their use in treating neoplastic disease including cancer and large tumors. RNA and DNA viruses are useful in this regard. The invention also relates to methods for the selection, design, purification and use of such viruses for cancer therapy.

Treatment Of Neoplasms With Viruses

View page
US Patent:
20030044384, Mar 6, 2003
Filed:
Jan 15, 2002
Appl. No.:
10/044955
Inventors:
Michael Roberts - Walkersville MD, US
Robert Lorence - Bethesda MD, US
William Groene - New Market MD, US
Harvey Rabin - Rockville MD, US
Reid von Borstel - Potomac MD, US
Assignee:
Pro-Virus, Inc.
International Classification:
A61K048/00
C12N007/00
C12N015/86
US Classification:
424/093200, 435/456000, 435/235100
Abstract:
The subject invention relates to viruses that are able to replicate and thereby kill neoplastic cells with a deficiency in the IFN-mediated antiviral response, and their use in treating neoplastic disease including cancer and large tumors. RNA and DNA viruses are useful in this regard. The invention also relates to methods for the selection, design, purification and use of such viruses for cancer therapy.

Newcastle Disease Virus Administration

View page
US Patent:
20070077559, Apr 5, 2007
Filed:
Mar 2, 2004
Appl. No.:
10/548057
Inventors:
Michael Bamat - Potomac MD, US
Robert Lorence - Bethesda MD, US
Pierre Major - Hamilton, CA
Harvey Rabin - Rockville MD, US
Michael Roberts - Myersville MD, US
International Classification:
C12Q 1/70
C12Q 1/68
US Classification:
435006000, 435005000
Abstract:
A mammalian subject having a tumor is treated by a method comprising administering an effective amount of a Newcastle disease virus, wherein the virus is administered to the subject in one or more cycles; and at least one cycle comprises administering sequentially one or more initial doses of from 1.8×10PFU to 4.8×10PFU of the virus per square meter of patient surface area followed by administering one or more subsequent doses of from 2.4×10PFU to 1.2×10PFU of the virus per square meter of patient surface area.

Test Methods Employing Monoclonal Antibodies Against Herpes Simplex Virus Types 1 And 2 Nucleocapsids Proteins

View page
US Patent:
44304374, Feb 7, 1984
Filed:
Aug 27, 1980
Appl. No.:
6/181954
Inventors:
Berge Hampar - Middletown MD
Martin Zweig - Walkersville MD
Harvey Rabin - Braddock Heights MD
Conrad J. Heilman - Chester NY
Ralph F. Hopkins - Frederick MD
Russell H. Neubauer - Frederick MD
Assignee:
The United States of America as represented by the Department of Health
and Human Services - Washington DC
International Classification:
G01N 3354
G01N 3356
G01N 3358
US Classification:
436548
Abstract:
The method of producing clinical assays for use of monoclonal antibodies in the diagnosis of Herpes simplex virus (HSV) infections and the differentiation of Herpes Simplex virus types 1 and 2 as a diagnostic kit for differentiating HSV-1 and HSV-2 utilizing clone 1D4 against HSV-1 and clone 3E1 against HSV-2.
Control profile
Harvey Rabin from Braddock Heights, MD Get Report